{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T22:15:43Z","timestamp":1786313743379,"version":"build-2736575974"},"reference-count":22,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2014,4,14]],"date-time":"2014-04-14T00:00:00Z","timestamp":1397433600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0094462","type":"journal-article","created":{"date-parts":[[2014,4,14]],"date-time":"2014-04-14T20:31:59Z","timestamp":1397507519000},"page":"e94462","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":158,"title":["Mycobactericidal Activity of Sutezolid (PNU-100480) in Sputum (EBA) and Blood (WBA) of Patients with Pulmonary Tuberculosis"],"prefix":"10.1371","volume":"9","clinical-trial-number":[{"clinical-trial-number":"nct01225640","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Robert S.","family":"Wallis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven O.","family":"Friedrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amour","family":"Venter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darcy","family":"Paige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Silvia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Gobey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Ellery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Eisenach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas H.","family":"Diacon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,4,14]]},"reference":[{"key":"ref1","unstructured":"World Health Organization (2010) Multidrug and extensively drug-resistant TB (M\/XDR-TB): 2010 Global report on surveillance and response. WHO\/HTM\/TB\/2010.3."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1128\/AAC.01411-05","article-title":"Inhibition of mammalian mitochondrial protein synthesis by oxazolidinones","volume":"50","author":"EE McKee","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1056\/NEJMoa1201964","article-title":"Linezolid for the treatment of chronic extensively drug-resistant tuberculosis","volume":"367","author":"M Lee","year":"2012","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1164\/rccm.200904-0611OC","article-title":"Addition of PNU-100480 to first-line drugs shortens the time needed to cure murine tuberculosis","volume":"180","author":"KN Williams","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1128\/AAC.01179-10","article-title":"Biomarker assisted dose selection for safety and efficacy in early development of PNU-100480 for tuberculosis","volume":"55","author":"RS Wallis","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"ref6","unstructured":"Louie A, Eichas K, Files K, Swift M, Bahniuk N, et al. (2011) Activities of PNU-100480 (PNU 480) alone, PNU 480 plus its major metabolite PNU-101603 (PNU 1603) and PNU 480 plus PNU 1603 in combination with rifampin (RIF) against Mycobacterium tuberculosis: Comparison with linezolid. ICAAC 51. Abstract A1\u20131737."},{"key":"ref7","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1086\/655471","article-title":"Pharmacokinetics and whole blood bactericidal activity against Mycobacterium tuberculosis of single ascending doses of PNU-100480 in healthy volunteers","volume":"202","author":"RS Wallis","year":"2010","journal-title":"J Infect Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/pds.1211","article-title":"Hy's law: predicting serious hepatotoxicity","volume":"15","author":"R Temple","year":"2006","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1164\/rccm.200806-892OC","article-title":"Early and Extended Early Bactericidal Activity of Linezolid in Pulmonary Tuberculosis","volume":"178","author":"R Dietze","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1128\/AAC.01204-07","article-title":"Early bactericidal activity and pharmacokinetics of the Diarylquinoline TMC 207 in pulmonary tuberculosis","volume":"52","author":"R Rustomjee","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1128\/AAC.01354-09","article-title":"Early bactericidal activity and pharmacokinetics of PA-824 in smear-positive tuberculosis patients","volume":"54","author":"AH Diacon","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0140-6736(13)60041-0","article-title":"Early bactericidal activity of new drug regimens for tuberculosis","volume":"381","author":"RS Wallis","year":"2013","journal-title":"Lancet"},{"key":"ref13","unstructured":"Louie A, Brown D, Files K, Swift M, Fikes S, et al. (2012) Pharmacodynamics of PNU-100480 (sutezolid), a new oxazolidinone, in combination with its active metabolite in the killing of M. tuberculosis in an in vitro hollow fiber infection model. ICAAC A-1265."},{"key":"ref14","unstructured":"Converse PJ, Lee J, Williams KN, Dionne K, Parrish N, et al. (2012) Activity of PNU-100480 and its major metabolite in whole blood and broth culture models of tuberculosis. Amer Soc Microbiol 112. Abstract GM-A-2052."},{"key":"ref15","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1086\/346053","article-title":"Whole blood bactericidal activity during treatment of pulmonary tuberculosis","volume":"187","author":"RS Wallis","year":"2003","journal-title":"J Infect Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S1473-3099(10)70003-7","article-title":"Biomarkers for tuberculosis disease activity, cure, and relapse","volume":"10","author":"RS Wallis","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1164\/rccm.201105-0850OC","article-title":"A comparison between two strategies for monitoring hepatic function during antituberculous therapy","volume":"185","author":"A Singanayagam","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e26254","DOI":"10.1371\/journal.pone.0026254","article-title":"Evidence for oxidative stress and defective antioxidant response in guinea pigs with tuberculosis","volume":"6","author":"GS Palanisamy","year":"2011","journal-title":"PLoS ONE"},{"key":"ref19","first-page":"97","article-title":"Induction of oxidative stress in antitubercular drug-induced hepatotoxicity","volume":"20","author":"A Chowdhury","year":"2001","journal-title":"Indian J Gastroenterol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.micpath.2007.09.002","article-title":"Glutathione levels and immune responses in tuberculosis patients","volume":"44","author":"V Venketaraman","year":"2008","journal-title":"Microb Pathog"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/cbf.1039","article-title":"Lipid peroxidation, vitamins C, E and reduced glutathione levels in patients with pulmonary tuberculosis","volume":"22","author":"M Vijayamalini","year":"2004","journal-title":"Cell Biochem Funct"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1097\/MEG.0b013e32833aa11b","article-title":"Protective effect of N-acetylcysteine on antituberculosis drug-induced hepatotoxicity","volume":"22","author":"S Baniasadi","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0094462","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T02:58:12Z","timestamp":1588993092000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0094462"}},"subtitle":[],"editor":[{"given":"Sarah L.","family":"Pett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,4,14]]},"references-count":22,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,4,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0094462","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,14]]}}}